跳至主要内容
临床试验/EUCTR2005-002777-68-GB
EUCTR2005-002777-68-GB进行中(未招募)1 期

The effects of rosuvastatin therapy on glucose metabolism in non-diabetic renal transplant recipients with a focus on insulin sensitivity and pancreatic beta islet cell function - Statins, renal transplantation and glucose metabolism

Cardiff and Vale NHS Trust0 个研究点目标入组 20 人开始时间: 2006年7月23日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

入选标准

  • Caucasian, non-diabetic renal transplant recipients, with stable allograft function under the care of the Nephrology and Transplant Directorate, University Hospital of Wales, Cardiff. Subjects can be 6 months to 10 years post-transplantation, at the time of randomisation.
  • Primary immunosuppression: Tacrolimus
  • Subjects should have a total cholesterol = 4.5mmol/l and/or LDL cholesterol = 2.5 mmol/l)
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • 1.Pregnancy or current breast feeding
  • 2.History of cardiovascular disease
  • 3.Fasting cholesterol of > 8 mmol/l
  • 4.Unstable allograft function
  • 5.Diabetic subjects
  • 6.Non-Caucasian patients

研究者

发起方
Cardiff and Vale NHS Trust

相似试验

The effects of rosuvastatin therapy on glucose... | 临床试验